CA-CROWN-BIOSCIENCE
Crown Bioscience Invests in Process Excellence with the Appointment of New Vice President of Global Quality
Crown Bioscience today announces the appointment of Pam Shang as vice president for global quality. Mrs. Shang will be instrumental in further enhancing global quality across the company, leveraging her deep expertise in implementing quality systems for pharma and biotechnology clients including in GLP, GMP and other regulated environments.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201008005432/en/
Building on CrownBio’s existing platforms, Mrs. Shang will be responsible for the strategic direction, enhancement, and growth of CrownBio’s quality systems, underlying organizational processes, and leading the associated change management.
“I am excited to welcome Pam to the leadership team,” said Armin Spura, PhD, chief executive officer of CrownBio. “With her wealth of experience in implementing global quality systems and overseeing GxP initiatives, Pam will ensure that CrownBio puts quality and our customers at the forefront of all CrownBio initiatives”.
Mrs. Shang joins CrownBio from Asahi Kasei America, a Japanese pharmaceutical company, where she was head of global quality and compliance. Pam was responsible for all regulatory matters across diverse areas including quality oversight and control, regulatory compliance, and audit management.
CrownBio has seen consistent quality improvements year-on-year, with associated enhanced client satisfaction. The new strategic initiatives led by Mrs. Shang across global operational platforms will ensure high scientific quality and a continued dedication to enhance standards and performance across the company.
“I’m delighted to bring my expertise to CrownBio”, said Pam Shang. “The quality of our work and compliance to regulatory standards is extremely important, and pivotal for CrownBio’s continued growth. My aim is to ensure that all staff are empowered with proper resources and regulatory knowledge to be successful and accountable, to foster a success-oriented, safe working environment and to ensure the scientific quality of our products and services”.
Mrs. Shang holds a BS in Management Information Systems and a minor in Business from Southern Illinois University. She also completed Master’s Program course requirements in Biotechnology at Harvard University.
About Crown Bioscience Inc.
Crown Bioscience, a JSR Life Sciences company, is a global drug discovery and development service company providing translational platforms to advance oncology, inflammation, and metabolic disease research. With an extensive portfolio of relevant models and predictive tools, Crown Bioscience enables clients to deliver superior clinical candidates. For more information, visit:
View source version on businesswire.com: https://www.businesswire.com/news/home/20201008005432/en/
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
ONWARD27.1.2021 17:02:08 CET | Press release
ONWARD Announces Publication in Nature Demonstrating Blood Pressure Stabilization in People with Spinal Cord Injury
CA-ESRI27.1.2021 17:02:08 CET | Press release
Esri Launches ArcGIS Platform
CA-XSOLLA27.1.2021 16:34:07 CET | Press release
Xsolla Establishes New Games Industry Collective, Xsolla Diamond Club
CA-C3-AI27.1.2021 15:02:11 CET | Press release
C3 AI Reinvents No Code AI with the Introduction of C3 AI Ex Machina
NY-UNITEDLEX27.1.2021 14:40:09 CET | Press release
UnitedLex Integrates Microsoft Cloud to Globally Scale Digital Transformation of Legal Services
NY-PHILIP-MORRIS-INTL27.1.2021 14:20:08 CET | Press release
Philip Morris International Named to the 2021 Bloomberg Gender-Equality Index, Recognizing Company’s Commitment to Advancing Gender Equity
NY-COTY27.1.2021 14:12:07 CET | Press release
Coty Announces Consolidation of Fragrance Manufacturing Operations with Intended Closure of Site in Cologne, Germany
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom